As a Centers for Disease Control and Prevention advisory committee prepares to consider expanding COVID-19 vaccine eligibility to children aged 5-11, the AHA, American Academy of Pediatrics and Children’s Hospital Association will webcast a panel discussion Nov. 8 at 2 p.m. ET on how pediatricians and hospitals can work with parents to build trust in the safety and efficacy of the COVID-19 vaccine for children. Panelists Yvonne Maldonado, M.D., chief of pediatric infectious diseases at Stanford University School of Medicine; Lee Savio Beers, M.D., AAP president and professor of pediatrics and medical director for community health and advocacy at Children’s National Hospital; Elise Herman, M.D., a pediatrician at Kittitas Valley Healthcare-Ellensburg, Wash.; and Andrew Pavia, M.D., chief of pediatric infectious diseases at Intermountain Primary Children’s Hospital also will discuss strategies to protect children and keep them in school and how hospitals can partner with local schools, school boards, PTAs and teachers to build vaccine confidence. Register for the webinar here.

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…